Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

CombiGene AB

CombiGene’s vision is to provide patients affected by severe life-altering diseases with the prospect of a better life through novel gene therapies. CombiGene’s business concept is to develop effective gene therapies for severe life-altering diseases where adequate treatment is currently lacking. Development assets are sourced from an external research network and developed to achieve clinical proof of concept. Drug candidates for common diseases will be co-developed and commercialized through strategic partnerships, while the company may manage this process on its own for drugs targeting niched patient populations. The Company has an exclusive collaboration and licensing agreement for the CG01 project with Spark Therapeutics. The company is public and listed on the Swedish marketplace Nasdaq First North Growth Market and the company’s Certified Advisor is FNCA Sweden AB, +46 (0)852 80 03 99 *


Period Start 2018-01-12 existent
Products Industry gene therapy
  Industry 2 CG01 gene therapy (CombiGene)
Persons Person Ekolind, Peter (CombiGene 202310 CEO)
  Person 2 Nilsson, Jan (CombiGene 201610– CEO before NeuroVive + Pergamum + Tripep)
Region Region Lund
  Country Sweden
  Street 52A Agavägen
  City 18155 Lidingö
    Address record changed: 2024-01-05
Basic data Employees n. a.
    * Document for »About Section«: CombiGene AB. (1/25/22). "Press Release: CombiGene Signs Agreement to Evaluate the Leading Gene Therapy Candidate within the Lipodystrophy Project CGT2".
Record changed: 2024-06-07


Picture Berlin Partner Top News Captain T Cell Therapies 650x200px

More documents for CombiGene AB

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top